학술논문

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; AUG 15 2019, 25 16, p4888-p4897, 10p.
Subject
Language
English
ISSN
15573265